Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2746)
All Articles published online
|
May 21, 2009 (publication date) through Dec 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Salcido-Neyoy ME, Sierra-Santoyo A, Beltrán-Ramírez O, Macías-Pérez JR, Villa-Treviño S. Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer. World J Gastroenterol 2009; 15(19): 2345-2350 [PMID: 19452576 DOI: 10.3748/wjg.15.2345] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i19/2345.htm |
| Number | Citing Articles |
| 1 |
Mohamed I.F. Shariff, Joshua M. Tognarelli, Matthew R. Lewis, Elizabeth J. Want, Fatma El Zahra Mohamed, Nimzing G. Ladep, Mary M.E. Crossey, Shahid A. Khan, Rajiv Jalan, Elaine Holmes, Simon D. Taylor-Robinson. Plasma Lipid Profiling in a Rat Model of Hepatocellular Carcinoma: Potential Modulation Through Quinolone Administration. Journal of Clinical and Experimental Hepatology 2015; 5(4): 286 doi: 10.1016/j.jceh.2015.07.205
|
| 2 |
Jaime Arellanes-Robledo, Martha Estela Salcido-Neyoy, Adriana Márquez-Quiñones, Rebeca García-Román, Olga Beltrán-Ramírez, Véronique Le Berre, Sergueï Sokol, Jean Marie François, Saúl Villa-Treviño. Celecoxib activates Stat5 and restores or increases the expression of growth hormone-regulated genes in hepatocarcinogenesis. Anti-Cancer Drugs 2010; 21(4): 411 doi: 10.1097/CAD.0b013e328336e907
|
| 3 |
Suresh Kumar Nayudu, Shanti Badipatla, Masooma Niazi, Bhavna Balar. Cholestatic Hepatitis with Small Duct Injury Associated with Celecoxib. Case Reports in Medicine 2013; 2013: 1 doi: 10.1155/2013/315479
|
| 4 |
Ekaterina A. Korobkova. Effect of Natural Polyphenols on CYP Metabolism: Implications for Diseases. Chemical Research in Toxicology 2015; 28(7): 1359 doi: 10.1021/acs.chemrestox.5b00121
|
| 5 |
Chun-Chieh Yeh, Pei-Ying Liao, Sudhir Pandey, Su-Yung Yung, Hsueh-Chou Lai, Long-Bin Jeng, Wei-Chun Chang, Wen-Lung Ma. Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.572861
|
| 6 |
Olga Beltrán-Ramírez, Roberto Macías Pérez, Adolfo Sierra-Santoyo, Saúl Villa-Treviño. Cancer Prevention Mediated by Caffeic Acid Phenethyl Ester Involves Cyp2b1/2 Modulation in Hepatocarcinogenesis. Toxicologic Pathology 2012; 40(3): 466 doi: 10.1177/0192623311431947
|
| 7 |
Brisa Rodope Alarcón-Sánchez, Julio Isael Pérez-Carreón, Saúl Villa-Treviño, Jaime Arellanes-Robledo. Molecular alterations that precede the establishment of the hallmarks of cancer: An approach on the prevention of hepatocarcinogenesis. Biochemical Pharmacology 2021; 194: 114818 doi: 10.1016/j.bcp.2021.114818
|
| 8 |
Larissa Widholzer Galant, Ângelo Alves de Mattos, Eduardo Menti, Fabiana Borba Valiatti, Ângelo Zambam de Mattos, Marilene Porawski, Antônio Hartmann, Cláudia Ramos Rhoden. The effect of celecoxib on the development of diethylnitrosamine-induced liver tumors in rats. Annals of Hepatology 2013; 12(3): 425 doi: 10.1016/S1665-2681(19)31005-1
|
| 9 |
Jian Chen, Peng Shen, Xiao-chen Zhang, Meng-dan Zhao, Xing-guo Zhang, Liu Yang. Efficacy and Safety Profile of Celecoxib for Treating Advanced Cancers: A Meta-analysis of 11 Randomized Clinical Trials. Clinical Therapeutics 2014; 36(8): 1253 doi: 10.1016/j.clinthera.2014.06.015
|